Free Trial
LON:SNG

Synairgen (SNG) Share Price, News & Analysis

GBX 5.70
-0.04 (-0.61%)
(As of 05:07 AM ET)
Today's Range
5.40
5.70
50-Day Range
5.60
7.55
52-Week Range
4
11
Volume
38,818 shs
Average Volume
346,522 shs
Market Capitalization
£11.48 million
P/E Ratio
N/A
Dividend Yield
1.53%
Price Target
N/A
SNG stock logo

About Synairgen Stock (LON:SNG)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

SNG Stock Price History

SNG Stock News Headlines

Suominen Ord Share Chat
Discover AI Giants?
Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Primorus Inv. Share Chat
Sonagi SGPS SA SNG
Synairgen plc (SNG.L)
Discover AI Giants?
Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Synairgen PLC SYGGF
Synairgen PLC OMY
Synairgen PLC SNG
SNGN Romgaz SA SNG
Synairgen takes targeted approach with lead asset
SNG.L - Synairgen plc
Companies Like Synairgen (LON:SNG) Could Be Quite Risky
See More Headlines
Receive SNG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synairgen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/29/2020
Today
6/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
34
Year Founded
N/A

Profitability

Net Income
£-42,870,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£79,000.00
Cash Flow
GBX 3 per share
Book Value
GBX 26 per share

Miscellaneous

Free Float
N/A
Market Cap
£11.48 million
Optionable
Not Optionable
Beta
-2.23
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Richard Marsden (Age 57)
    CEO, MD & Executive Director
    Comp: $328k
  • Prof. Stephen T. Holgate CBE (Age 77)
    M.D., Co-Founder, Non-Executive Director & Member of Scientific Advisory Board
    Comp: $44k
  • Dr. Phillip David Monk (Age 55)
    Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director
    Comp: $240k
  • Prof. Donna Davies
    Co-Founder & Member of Scientific Advisory Board
  • Prof. Ratko Djukanovic
    Co-Founder & Member of Scientific Advisory Board
  • Mr. Joseph Tregonning Colliver F.C.A. (Age 44)
    CFO & Executive Director
  • Dr. Gareth E. Walters Ph.D. (Age 65)
    Chief Regulatory Officer
  • Ms. Jody Brookes
    Senior VP & Head of Clinical Operations
  • Mr. Richard Francis
    Senior VP and Head of CMC & Quality
  • Dr. Victoria Tear
    Head of Laboratory

SNG Stock Analysis - Frequently Asked Questions

How have SNG shares performed in 2024?

Synairgen's stock was trading at GBX 5.98 at the beginning of 2024. Since then, SNG shares have decreased by 4.0% and is now trading at GBX 5.74.
View the best growth stocks for 2024 here
.

How were Synairgen's earnings last quarter?

Synairgen plc (LON:SNG) released its earnings results on Tuesday, September, 29th. The company reported ($3.11) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Synairgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Alibaba Group (BABA), Yamana Gold (YRI), Eldorado Gold (ELD), Ocado Group (OCDO), Polo Resources (POL), Silvercorp Metals (SVM), W Resources (WRES), Associated British Foods (ABF), Ariana Resources (AAU) and First Majestic Silver (AG).

How do I buy shares of Synairgen?

Shares of SNG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SNG) was last updated on 6/24/2024 by MarketBeat.com Staff

From Our Partners